CagriSema

Description

Components Cagrilintide: 10mgSemaglutide: 10mg CAS Numbers Cagrilintide: 2133459-98-0Semaglutide: 910463-68-2 Molecular Weights Cagrilintide: ~7342.5 g/molSemaglutide: ~4113.6 g/mol

Form: Lyophilized Powder
Quantity: 20mg total
Purity: ≥ 98 percent (HPLC Verified)

Product Overview

CagriSema is a research peptide blend that combines Cagrilintide, a long-acting amylin analog, with Semaglutide, a GLP-1 receptor agonist. This dual-hormone combination is used in metabolic research to explore appetite control, delayed gastric emptying, caloric intake reduction, and weight regulation. Studies show that targeting both amylin and GLP-1 receptors may produce stronger effects than using either compound alone. Key Areas of Research

Obesity and metabolic disease models Synergy in appetite and satiety pathways Gastric motility and energy intake regulation Multi-receptor metabolic therapy strategies

Applications in Research

Appetite and food intake studies Weight regulation models Receptor crosstalk and hormonal synergy Advanced multi-agonist metabolic pathway research

Storage and Handling

Store the lyophilized blend at minus 20°C in a dry and dark environment. Reconstitute with sterile bacteriostatic water to support laboratory use. After reconstitution, keep refrigerated and use within appropriate timeframes. Avoid repeated freeze and thaw cycles.

Research Use Only – Legal Disclaimer

All Eagle Peptides products labeled as Research Use Only (RUO) are intended strictly for laboratory, investigational, and scientific research purposes. These materials are not approved by the FDA and are not intended for human or veterinary use, clinical applications, diagnostic procedures, or therapeutic treatment of any kind. By purchasing or using RUO materials, you acknowledge that they will be handled only within an appropriate research environment by qualified personnel who understand the risks, limitations, and regulatory requirements associated with experimental compounds. Products must not be administered to humans or animals, offered as therapeutic agents, or represented as safe or effective for any medical purpose. Use of these materials is entirely at your own risk. Eagle Peptides assumes no liability for misuse, unsafe handling, improper application, or any regulatory or compliance issues arising from their use.